Hudson Bay Capital Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.95M Sell
913,109
-403,311
-31% -$1.55M 0.01% 572
2026
Q1
$3M Sell
1,316,420
-143,580
-10% -$455K 0.01% 657
2025
Q4
$5.84M Buy
1,460,000
+883,990
+153% +$4.91M 0.02% 465
2025
Q3
$4.87M Sell
576,010
-184,201
-24% -$1.79M 0.02% 558
2025
Q2
$8.56M Buy
760,211
+364,664
+92% +$3.35M 0.03% 388
2025
Q1
$3.75M Sell
395,547
-617,720
-61% -$6.24M 0.01% 676
2024
Q4
$11.4M Buy
1,013,267
+601,436
+146% +$10.6M 0.04% 337
2024
Q3
$11.6M Buy
+411,831
New +$10.6M 0.05% 255

Other funds holding EVH

Hudson Bay Capital Management's EVH Position: Q2 2026 in Review

Hudson Bay Capital Management reduced its Evolent Health (EVH) stake by 31% in Q2 2026, selling an estimated $1.55M and leaving 913,109 shares worth $4.95M. The position accounts for 0.01% of the portfolio, ranked #572.

Hudson Bay Capital Management first reported a position in EVH in Q3 2024 and has held it in 8 quarters since. The position peaked at $11.6M in Q3 2024. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Hudson Bay Capital Management held 913,109 shares of Evolent Health worth $4.95M as of Q2 2026.
  • Hudson Bay Capital Management sold 403,311 Evolent Health shares in Q2 2026, an estimated $1.55M.
  • Evolent Health made up 0.01% of Hudson Bay Capital Management's portfolio in Q2 2026, its #572 holding.
  • Hudson Bay Capital Management first reported a position in Evolent Health in Q3 2024 and has held it in 8 quarters since.
  • Hudson Bay Capital Management's Evolent Health position peaked at $11.6M in Q3 2024.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.